Other The innovators working to make in vivo cell therapy a reality Pharmaceutical TechnologyAs in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.OtherGene Therapy PlatformRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaceutical Technology As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability. OtherGene Therapy PlatformRead full story Post navigation Previous: Trump names Erica Schwartz to fill leadership void at CDCNext: Aligos and Xiamen Amoytop sign deal for HBV therapy Related Stories Other Takeda and Weave Bio collaborate on AI-driven automation in drug development pharminent September 2, 2026 Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026